# Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/fixed-dose-rate-gemcitabine-plus-docetaxel-as-second-line-therapy-for-metastatic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Martee L. Hensley,John A. Blessing,Koen DeGeest,Ovadia Abulafia,Peter G. Rose,Howard D. Homesley |
| Citations | 365 |
| DOI | 10.1016/j.ygyno.2008.02.024 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/2692926 |
| OpenAlex ID | https://openalex.org/W2136309235 |
| PMID | 18394689 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Peter G. Rose](https://scholariq.org/researchers/peter-g-rose/)

## Paper journal

- [Gynecologic Oncology](https://scholariq.org/journals/gynecologic-oncology/)

## Paper primary topic

- [Uterine Myomas and Treatments](https://scholariq.org/topics/uterine-myomas-and-treatments/)

## Paper topics

- [Uterine Myomas and Treatments](https://scholariq.org/topics/uterine-myomas-and-treatments/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.